LADENBURG THALMANN FINANCIAL SERVICES INC. - HOMOLOGY MEDICINES INC ownership

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q4 2019$401,000
+14.2%
19,3700.0%0.00%
+50.0%
Q3 2019$351,000
-7.4%
19,3700.0%0.00%
-33.3%
Q2 2019$379,000
+36.8%
19,370
+93.7%
0.00%
+50.0%
Q1 2019$277,000
+23.7%
10,0000.0%0.00%0.0%
Q4 2018$224,000
-2.2%
10,0000.0%0.00%0.0%
Q3 2018$229,00010,0000.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q2 2024
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$16,511,0003.10%
Vida Ventures Advisors, LLC 770,845$2,806,0001.05%
Vivo Capital, LLC 853,143$3,105,0000.19%
AAF Wealth Management, LLC 47,501$173,0000.12%
OUP Management Co., LLC 64,000$233,0000.10%
GSA CAPITAL PARTNERS LLP 195,596$712,0000.09%
Temasek Holdings (Private) Ltd 5,650,996$20,570,0000.07%
Bellevue Group AG 1,737,122$6,323,0000.06%
XTX Topco Ltd 26,212$95,0000.05%
Virtus ETF Advisers LLC 37,588$137,0000.05%
View complete list of HOMOLOGY MEDICINES INC shareholders